Carol A. Davis

880 total citations
26 papers, 673 citations indexed

About

Carol A. Davis is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carol A. Davis has authored 26 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carol A. Davis's work include Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and CAR-T cell therapy research (2 papers). Carol A. Davis is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and CAR-T cell therapy research (2 papers). Carol A. Davis collaborates with scholars based in United States. Carol A. Davis's co-authors include Judith C. Rembert, J. C. Greenfield, Henry J. Durivage, Francis D. Galey, Thomas E. Goetz, Herbert E. Whiteley, Val R. Beasley, Karol H. Katz, Judith Marsh and Joseph R. Bertino and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer.

In The Last Decade

Carol A. Davis

26 papers receiving 657 citations

Peers

Carol A. Davis

ONCOL

CCM

EQUIN

IMMUN

Cornelis J. Cornelisse United States

Nozomu Yokoyama Japan

C A Bouvier Switzerland

Ayman El Nahas Saudi Arabia

G. O. Broun United States

Amy Usborne United States

Märta Knös Germany

Kiyomi Kimura Japan

Olivier Bonneau Switzerland

Andreas R. Huber Switzerland

Cornelis J. Cornelisse United States

Carol A. Davis

134 ×0.6

117 ×0.8

ONCOL

69 ×0.5

CCM

147 ×1.9

EQUIN

8 ×0.1

IMMUN

Citations per year, relative to Carol A. Davis Carol A. Davis (= 1×) peers Cornelis J. Cornelisse

Countries citing papers authored by Carol A. Davis

Since Specialization

Citations

This map shows the geographic impact of Carol A. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Davis more than expected).

Fields of papers citing papers by Carol A. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Davis. The network helps show where Carol A. Davis may publish in the future.

Co-authorship network of co-authors of Carol A. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Davis. A scholar is included among the top collaborators of Carol A. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Davis. Carol A. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrne, Kevin P., et al.. (2000). The effects of dietary n‐3 vs. n‐6 fatty acids on ex‐vivo LTB₄ generation by canine neutrophils. Veterinary Dermatology. 11(2). 123–131. 10 indexed citations

Davis, Carol A.. (2000). Test of intron predictions reveals novel splice sites, alternatively spliced mRNAs and new introns in meiotically regulated genes of yeast. Nucleic Acids Research. 28(8). 1700–1706. 131 indexed citations

Chambers, Suzanne K., J.T. Chambers, Carol A. Davis, et al.. (1997). Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients.. Journal of Clinical Oncology. 15(5). 1945–1952. 12 indexed citations

Chambers, Setsuko K., Carol A. Davis, Peter E. Schwartz, Ernest I. Kohorn, & Joseph T. Chambers. (1996). Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.. PubMed. 2(10). 1693–7. 8 indexed citations

Chambers, Suzanne K., et al.. (1996). Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.. PubMed. 2(10). 1699–704. 9 indexed citations

Braverman, Irwin M., Andreas H. Sarris, Henry J. Durivage, et al.. (1993). Cyclosporine treatment of refractory T-cell lymphomas. Cancer. 71(7). 2335–2341. 30 indexed citations

Marsh, John C., et al.. (1992). Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy. American Journal of Clinical Oncology. 15(2). 115–118. 2 indexed citations

Galey, Francis D., et al.. (1991). Black walnut (Juglans nigra) toxicosis: A model for equine laminitis. Journal of Comparative Pathology. 104(3). 313–326. 61 indexed citations

Benson, G. John, Laura Wheaton, J. C. Thurmon, et al.. (1991). Postoperative Catecholamine Response to Onychectomy in Isoflurane‐anesthetized Cats Effect of Analgesics. Veterinary Surgery. 20(3). 222–225. 42 indexed citations

10.

Murren, John R., et al.. (1991). High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma. Cancer. 67(6). 1514–1517. 17 indexed citations

11.

Murren, John R., Andreas H. Sarris, Henry J. Durivage, et al.. (1991). A Phase II Trial of Cyclosporin A in the Treatment of Refractory Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 14(3). 208–217. 4 indexed citations

12.

Marsh, Judith, Joseph R. Bertino, Karol H. Katz, et al.. (1991). The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.. Journal of Clinical Oncology. 9(3). 371–380. 85 indexed citations

13.

Campbell, Karen & Carol A. Davis. (1990). Effects of thyroid hormones on serum and cutaneous fatty acid concentrations in dogs. American Journal of Veterinary Research. 51(5). 752–756. 14 indexed citations

14.

Kirkwood, John M., Marc S. Ernstoff, Yuichi Nishida, et al.. (1990). In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.. Journal of Clinical Oncology. 8(6). 1070–1082. 16 indexed citations

15.

Herrmann, Hartmut, et al.. (1990). Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man. American Heart Journal. 120(2). 308–315. 28 indexed citations

16.

Davis, Carol A., Judith C. Rembert, & J. C. Greenfield. (1990). Compliance of left atrium with and without left atrium appendage. American Journal of Physiology-Heart and Circulatory Physiology. 259(4). H1006–H1008. 85 indexed citations

17.

Davis, Carol A., et al.. (1989). Hemodynamic and Electrocardiographic Effects of Ioversol During Cardiac Angiography. Investigative Radiology. 24(2). 138–144. 25 indexed citations

18.

Ernstoff, Marc S., Carol A. Davis, Steven D. Reich, et al.. (1987). A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.. Journal of Clinical Oncology. 5(11). 1804–1810. 42 indexed citations

19.

Papich, Mark G., Lloyd Davis, Carol A. Davis, Brendan C. McKiernan, & Scott A. Brown. (1986). Pharmacokinetics of procainamide hydrochloride in dogs. American Journal of Veterinary Research. 47(11). 2351–2358. 4 indexed citations

20.

Davis, Lloyd, J. Desmond Baggot, Carol A. Davis, & Thomas E. Powers. (1973). Elimination Kinetics of Pentobarbital in Nephrectomized Dogs. American Journal of Veterinary Research. 34(2). 231–233. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact